trimethobenzamide (Ticon)

Subscribe to Selected New Research on trimethobenzamide

25 relevant articles (1 outcomes, 2 trials/studies) found for this Drug

Description: major descriptor (64-84); on-line search BENZAMIDES (64-84); Index Medicus search TRIMETHOBENZAMIDE (64-84); RN given refers to parent cpd

Also Known As:

Ticon; Tigan; T-Gen; Tebamide; G & W brand of trimethobenzamide monohydrochloride; Goldline brand of trimethobenzamide monohydrochloride; Monarch brand of trimethobenzamide monohydrochloride; Roberts brand of trimethobenzamide monohydrochloride; trimethobenzamide monohydrochloride

Relationship Network

Drug Context: Research Results

Organic Chemicals: 40

Amides: 145

Benzamides: 63

trimethobenzamide: 25

trimethobenzamide: 25

Experts

1.	Corbo, Jill: 1 article (06/2006)
2.	Hochberg, Michael: 1 article (06/2006)
3.	Lipton, Richard B: 1 article (06/2006)
4.	Gallagher, E John: 1 article (06/2006)
5.	Esses, David: 1 article (06/2006)
6.	Solorzano, Clemencia: 1 article (06/2006)
7.	Bijur, Polly E: 1 article (06/2006)
8.	Friedman, Benjamin W: 1 article (06/2006)
9.	Paternoster, Joseph: 1 article (06/2006)
10.	Toosi, Babak: 1 article (06/2006)

Related Diseases

1.	Status Epilepticus (Complex Partial Status Epilepticus) 11/01/2000 - "Effect of theophylline and trimethobenzamide when given during kainate-induced status epilepticus: an improved histopathologic rat model of human hippocampal sclerosis." Get all the results and reference details, order at left...
2.	Sclerosis 11/01/2000 - "Effect of theophylline and trimethobenzamide when given during kainate-induced status epilepticus: an improved histopathologic rat model of human hippocampal sclerosis." Get all the results and reference details, order at left...
3.	Nausea 05/01/1980 - "Trimethobenzamide was shown to be significantly better than placebo in relieving periodic and total nausea over the 48-hour study" 01/01/1996 - "All 65 women took Tigan to prevent nausea, but 18.5% did not take it as prescribed" 01/01/1961 - "Use of trimethobenzamide in nausea associated with neoplastic disease." 06/01/1996 - "Oral trimethobenzamide was used to prevent apomorphine-induced nausea" 05/01/1980 - "Trimethobenzamide HCl in the treatment of nausea and vomiting associated with antineoplastic chemotherapy." Get all the results and reference details, order at left...
4.	Dental Plaque 05/01/1989 - "This segment of the study compares the accumulation of dental plaque, over time, on restorations made from either Olympia or one of several alternative alloys, including W-1, Ceramalloy II, Micro-Bond N/P2, or Ticon in comparison to: (1) an unrestored tooth, which served as the periodontal control, (2) Olympia, the alloy control, and (3) among the alternative alloys" Get all the results and reference details, order at left...
5.	Vomiting 05/01/1980 - "Vomiting incidence was also reduced in the group receiving trimethobenzamide" 04/09/1962 - "Results of the treatment of persistent vomiting with Tigan and Theadryl.]" 12/01/1960 - "Comparative study of the effectiveness of tigan and a placebo in controlling emesis." 04/01/1969 - "A clinical comparison of rectal pyrilamine maleate and trimethobenzamide hydrochloride for the control of vomiting in children." 05/01/1980 - "Trimethobenzamide HCl in the treatment of nausea and vomiting associated with antineoplastic chemotherapy." Get all the results and reference details, order at left...
17 Diseases and 25 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Theophylline (Theon)
2.	Kainic Acid (Kainate)
3.	Alloys
4.	Ceramalloy II
5.	trimethobenzamide (Ticon)
6.	Pyridoxine (Pyridoxin)
7.	Apomorphine
8.	bendectin
9.	Sumatriptan (Imigran)
10.	Thiethylperazine (Thiethylperazine Malate)
22 Drugs and Important Bio-Agents and 16 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplantation (Transplant Recipients)
2.	Drug Therapy (Chemotherapy)
2 Therapies and Procedures and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>